Clinical Trial Update: Identifying Predictors Of Response To Mepolizumab In CRSwNP [Phase 4]

View source ↗

Summary

Phase 4 trial identifying predictors of response to mepolizumab in chronic rhinosinusitis with nasal polyps (CRSwNP). Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Nucala (mepolizumab)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 4 | Status: RECRUITING